Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 512,182 | |
| Bona-fide gift | 2 | 416,146 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
22 Form 4 filings on record, the earliest from Oct 31, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James Rolke - Officer | Grant or award | Common Stock | 208,076 | $0.00 | - | |
| Lakhmir S. Chawla - Director | Grant or award | Common Stock | 32,011 | $0.00 | - | |
| Chester Stanley Zygmont III - Officer | Grant or award | Common Stock | 208,073 | $0.00 | - | |
| Chester Stanley Zygmont III - Officer | Gift | Common Stock | 208,073 | $0.00 | - | |
| Chester Stanley Zygmont III - Officer | Gift | Common Stock | 208,073 | $0.00 | - | |
| Jess Roper - Director | Grant or award | Common Stock | 32,011 | $0.00 | - | |
| Jennifer Carver - Director | Grant or award | Common Stock | 32,011 | $0.00 | - | |
| James Rolke - Officer | Tax withholding / forfeiture | Common Stock | 10,115 | $1.13 | $11K | |
| Chester Stanley Zygmont III - Officer | Tax withholding / forfeiture | Common Stock | 13,285 | $1.10 | $15K | |
| Jess Roper | Tax withholding / forfeiture | Common Stock | 1,591 | $1.85 | $3K | |
| Lakhmir S. Chawla | Tax withholding / forfeiture | Common Stock | 2,261 | $1.85 | $4K | |
| Jennifer Carver | Tax withholding / forfeiture | Common Stock | 1,661 | $1.87 | $3K | |
| James Rolke - Officer | Tax withholding / forfeiture | Common Stock | 8,521 | $1.86 | $16K | |
| Chester Stanley Zygmont III - Officer | Tax withholding / forfeiture | Common Stock | 13,100 | $1.65 | $22K | |
| James Rolke - Officer | Grant or award | Common Stock | 532,829 | $3.60 | $480K | |
| Chester Stanley Zygmont III - Officer | Grant or award | Common Stock | 78,145 | $3.60 | $70K | |
| Jennifer Carver | Grant or award | Common Stock | 41,981 | $3.60 | $38K | |
| Jess Roper | Grant or award | Common Stock | 41,981 | $3.60 | $38K | |
| Lakhmir S. Chawla | Grant or award | Common Stock | 41,981 | $3.60 | $38K | |
| Jess Roper | Grant or award | Common Stock | 15,625 | $5.12 | $20K | |
| James Rolke - Officer | Grant or award | Common Stock | 390,614 | $5.12 | $500K | |
| Chester Stanley Zygmont III - Officer | Grant or award | Common Stock | 390,614 | $5.12 | $500K | |
| Lakhmir S. Chawla | Grant or award | Common Stock | 15,625 | $5.12 | $20K | |
| Jennifer Carver | Grant or award | Common Stock | 15,625 | $5.12 | $20K |
REVELATION BIOSCIENCES, INC. (REVB) had 5 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for REVB runs to 22 Form 4 filings, the earliest from 2025-10-31. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of REVB were filed in the last 90 days.
No insider sales of REVB were filed in the last 90 days.
This page tracks REVB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add REVB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.